Atreca, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023019045 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.40M
YoY Change -75.04%
Cash & Equivalents $13.47M
Short-Term Investments $7.900M
Other Short-Term Assets $2.800M
YoY Change -28.26%
Inventory
Prepaid Expenses
Receivables
Other Receivables $180.0K
Total Short-Term Assets $24.69M
YoY Change -73.38%
LONG-TERM ASSETS
Property, Plant & Equipment $1.614M
YoY Change -95.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $1.649M
YoY Change -97.92%
TOTAL ASSETS
Total Short-Term Assets $24.69M
Total Long-Term Assets $1.649M
Total Assets $26.34M
YoY Change -84.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.062M
YoY Change 139.22%
Accrued Expenses $9.292M
YoY Change -1.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.58M
YoY Change 6.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.58M
Total Long-Term Liabilities $0.00
Total Liabilities $15.58M
YoY Change -79.45%
SHAREHOLDERS EQUITY
Retained Earnings -$533.3M
YoY Change 22.44%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.76M
YoY Change
Total Liabilities & Shareholders Equity $26.34M
YoY Change -84.69%

Cashflow Statement

Concept 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Address Line1
EntityAddressAddressLine1
835 Industrial Road, Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Carlos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94070
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
595-2595
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001532346
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Restricted Cash Asset Statement Of Financial Position Extensible List
RestrictedCashAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q4 us-gaap Restricted Cash Asset Statement Of Financial Position Extensible List
RestrictedCashAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q3 bcel Consecutive Business Days For Maintaining Bid Price Requirement In Grace Period
ConsecutiveBusinessDaysForMaintainingBidPriceRequirementInGracePeriod
P10D
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38935
dei Entity Registrant Name
EntityRegistrantName
ATRECA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3723255
dei Security12b Title
Security12bTitle
Class A Common Stock
dei Trading Symbol
TradingSymbol
BCEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13470000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30819000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
7918000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
39676000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3305000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7531000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
24693000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
78026000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1614000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37972000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36056000
CY2023Q3 bcel Deposits And Others
DepositsAndOthers
35000
CY2022Q4 bcel Deposits And Others
DepositsAndOthers
2976000
CY2023Q3 us-gaap Assets
Assets
26342000
CY2022Q4 us-gaap Assets
Assets
155030000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4062000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1741000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9292000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9681000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1281000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3544000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
948000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1327000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15583000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16293000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60331000
CY2023Q3 us-gaap Liabilities
Liabilities
15583000
CY2022Q4 us-gaap Liabilities
Liabilities
76624000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
544094000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
535592000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-266000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-533335000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456924000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10759000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
78406000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26342000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155030000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-8768000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10407000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16045000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36774000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53062000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5386000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7247000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20300000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23930000
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
20856000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
20856000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
36649000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
23292000
us-gaap Operating Expenses
OperatingExpenses
77930000
us-gaap Operating Expenses
OperatingExpenses
76992000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
80000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
243000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
750000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
354000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
233000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1276000
us-gaap Investment Income Interest
InvestmentIncomeInterest
430000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
434000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1519000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1180000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36215000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23059000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76411000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75812000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-36215000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23059000
us-gaap Net Income Loss
NetIncomeLoss
-76411000
us-gaap Net Income Loss
NetIncomeLoss
-75812000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.97
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39354502
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39354502
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38720575
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38720575
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39202045
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39202045
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38434327
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38434327
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-36215000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23059000
us-gaap Net Income Loss
NetIncomeLoss
-76411000
us-gaap Net Income Loss
NetIncomeLoss
-75812000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
80000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
262000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-479000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36221000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22979000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76149000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76291000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
115203000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
145000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3884000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
80000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23059000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
96253000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
44673000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2297000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-36215000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10759000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
154929000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3509000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
322000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13708000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-479000
us-gaap Net Income Loss
NetIncomeLoss
-75812000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
96253000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
78406000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
119000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8383000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
262000
us-gaap Net Income Loss
NetIncomeLoss
-76411000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10759000
us-gaap Profit Loss
ProfitLoss
-76411000
us-gaap Profit Loss
ProfitLoss
-75812000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3480000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4081000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1359000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1197000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
685000
us-gaap Share Based Compensation
ShareBasedCompensation
8383000
us-gaap Share Based Compensation
ShareBasedCompensation
13708000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
318000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-90000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7442000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2133000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
834000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1671000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1504000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2136000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-379000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-236000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1983000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2376000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49644000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65288000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
162000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
739000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
16647000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
60504000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
48985000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
48442000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32176000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12801000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
119000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
322000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3509000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
4000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3903000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17349000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-74186000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31934000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96204000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14585000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22018000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30000
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
275000
CY2023Q3 bcel Workforce Reduction Percentage
WorkforceReductionPercentage
0.40
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
1300000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
5100000
bcel Payments For Operating Lease Modification
PaymentsForOperatingLeaseModification
4000000.0
CY2023Q3 bcel Net Carrying Value Of Transferred Asset
NetCarryingValueOfTransferredAsset
32100000
CY2023Q3 bcel Consecutive Business Days For Maintaining Bid Price Requirement
ConsecutiveBusinessDaysForMaintainingBidPriceRequirement
P30D
CY2023Q3 bcel Bid Price Requirement Compliance Grace Period
BidPriceRequirementComplianceGracePeriod
P180D
CY2023Q3 bcel Bid Price Requirement Compliance Grace Period
BidPriceRequirementComplianceGracePeriod
P180D
CY2023Q3 bcel Bid Price Requirement Compliance Additional Grace Period
BidPriceRequirementComplianceAdditionalGracePeriod
P180D
CY2022Q4 bcel Interest Receivables And Other Current Assets
InterestReceivablesAndOtherCurrentAssets
174000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3305000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7531000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of income and expenses in the financial statements and accompanying notes. Actual results could differ from those estimates. Key estimates in the financial statements include estimated useful lives of property and equipment, impairment of long-lived assets, accrued expenses, valuation of deferred income tax assets, fair value of available-for-sale debt securities and fair value of options granted under the Company's stock option plan.</p>
CY2022Q4 bcel Accrued Research License Fees
AccruedResearchLicenseFees
3000000
CY2023Q3 bcel Accrued Contract Research Fees
AccruedContractResearchFees
2631000
CY2022Q4 bcel Accrued Contract Research Fees
AccruedContractResearchFees
2201000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
1100000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1100000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13470000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30819000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
1115000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1115000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14585000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31934000
CY2023Q3 bcel Accrued Lease Termination Fees
AccruedLeaseTerminationFees
1115000
CY2023Q3 bcel Accrued Costs To Terminate Contracts
AccruedCostsToTerminateContracts
500000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
153000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
128000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
60000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents, investments and other receivables included in prepaid and other current assets. Cash and cash equivalents are held at three financial institutions and were in excess of the Federal Deposit Insurance Corporation insurable limit at September 30, 2023 and December 31, 2022. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, result of operations, and cash flows. Additionally, cash and cash equivalents and investments are maintained at brokerage firms for which amounts are insured by the Securities Investor Protection Corporation subject to legal limits. The Company does not require collateral or other security for other receivables.</p>
CY2023Q3 bcel Number Of Financial Institutions Holding Cash And Cash Equivalents
NumberOfFinancialInstitutionsHoldingCashAndCashEquivalents
3
CY2022Q4 bcel Number Of Financial Institutions Holding Cash And Cash Equivalents
NumberOfFinancialInstitutionsHoldingCashAndCashEquivalents
3
CY2023Q3 us-gaap Supplies
Supplies
1064000
CY2022Q4 us-gaap Supplies
Supplies
2010000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1115000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
614000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1026000
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
336000
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
180000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3985000
CY2023Q3 bcel Interest Receivables And Other Current Assets
InterestReceivablesAndOtherCurrentAssets
332000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7626000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54724000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6012000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16752000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1614000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37972000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
900000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1400000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3500000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4100000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
400000
CY2023Q1 bcel Long Lived Assets Held For Sale Current
LongLivedAssetsHeldForSaleCurrent
100000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
700000
CY2023Q3 bcel Long Lived Assets Held For Sale Current
LongLivedAssetsHeldForSaleCurrent
300000
CY2023Q3 bcel Long Lived Assets Transferred Ownership Carrying Value
LongLivedAssetsTransferredOwnershipCarryingValue
32100000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
154000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3789000
CY2023Q3 bcel Accrued Severance Expense
AccruedSeveranceExpense
4679000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
563000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9292000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9681000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
5100000
CY2023Q3 bcel Net Carrying Value Of Transferred Asset
NetCarryingValueOfTransferredAsset
32100000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1281000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1281000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1281000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1281000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1281000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y2M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1500000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1500000
us-gaap Operating Lease Cost
OperatingLeaseCost
4400000
us-gaap Operating Lease Cost
OperatingLeaseCost
4400000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1000000.0
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
900000
us-gaap Variable Lease Cost
VariableLeaseCost
2900000
us-gaap Variable Lease Cost
VariableLeaseCost
2600000
bcel Strategic Financial Advisor Expenses
StrategicFinancialAdvisorExpenses
0
CY2023Q3 bcel Strategic Financial Advisor Expenses
StrategicFinancialAdvisorExpenses
0
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8888067
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7225635
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8888067
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7225635
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13700000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2297000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3884000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8383000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13708000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
bcel Defined Contribution Plan Employee Matching Contribution Threshold Amount
DefinedContributionPlanEmployeeMatchingContributionThresholdAmount
5000
CY2023Q3 bcel Defined Contribution Plan Total Matching Contributions
DefinedContributionPlanTotalMatchingContributions
0
CY2022Q3 bcel Defined Contribution Plan Total Matching Contributions
DefinedContributionPlanTotalMatchingContributions
100000
bcel Defined Contribution Plan Total Matching Contributions
DefinedContributionPlanTotalMatchingContributions
400000
bcel Defined Contribution Plan Total Matching Contributions
DefinedContributionPlanTotalMatchingContributions
600000

Files In Submission

Name View Source Status
bcel-20230930_cal.xml Edgar Link unprocessable
0001558370-23-019045-index-headers.html Edgar Link pending
0001558370-23-019045-index.html Edgar Link pending
0001558370-23-019045.txt Edgar Link pending
0001558370-23-019045-xbrl.zip Edgar Link pending
bcel-20230930.xsd Edgar Link pending
bcel-20230930x10q.htm Edgar Link pending
bcel-20230930xex31d1.htm Edgar Link pending
bcel-20230930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
bcel-20230930_lab.xml Edgar Link unprocessable
bcel-20230930_def.xml Edgar Link unprocessable
bcel-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bcel-20230930x10q_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending